Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chabot JA et al. – A controlled, observational study reports that among patients with pancreatic cancer, gemcitabine-based chemotherapy improved the survival time >3 times with a better quality of life vs proteolytic enzyme treatment.

Methods

Results


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address